. Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease. Alzheimers Dement (N Y). 2024;10(1):e12445. Epub 2024 Jan 26 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.